应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PRQR ProQR Therapeutics N.V.
盘前交易 07-11 05:16:41 EDT
2.36
+0.06
+2.61%
最高
2.38
最低
2.22
成交量
19.23万
今开
2.31
昨收
2.30
日振幅
6.80%
总市值
2.49亿
流通市值
1.56亿
总股本
1.05亿
成交额
44.02万
换手率
0.29%
流通股本
6,603万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Proqr Therapeutics N.V.2025财年第一财季实现净利润-10.61百万美元,同比减少27.68%
市场透视 · 05-17
Proqr Therapeutics N.V.2025财年第一财季实现净利润-10.61百万美元,同比减少27.68%
Proqr Therapeutics N.V.盘中异动 快速上涨5.16%
市场透视 · 05-15
Proqr Therapeutics N.V.盘中异动 快速上涨5.16%
奥本海默:维持ProQR Therapeutics评级,由优于大市调整至优于大市评级, 目标价由15.00美元调整至9.00美元。
金融界 · 05-13
奥本海默:维持ProQR Therapeutics评级,由优于大市调整至优于大市评级, 目标价由15.00美元调整至9.00美元。
Proqr Therapeutics N.V.盘中异动 大幅下跌5.73%报1.48美元
市场透视 · 05-08
Proqr Therapeutics N.V.盘中异动 大幅下跌5.73%报1.48美元
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.13%报1.64美元
市场透视 · 05-07
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.13%报1.64美元
Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.19%报1.81美元
市场透视 · 05-02
Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.19%报1.81美元
Proqr Therapeutics N.V.盘中异动 股价大涨5.16%报1.62美元
市场透视 · 04-29
Proqr Therapeutics N.V.盘中异动 股价大涨5.16%报1.62美元
Proqr Therapeutics N.V.盘中异动 急速下跌5.19%
市场透视 · 04-25
Proqr Therapeutics N.V.盘中异动 急速下跌5.19%
Proqr Therapeutics N.V.盘中异动 早盘大幅上涨6.06%
市场透视 · 04-22
Proqr Therapeutics N.V.盘中异动 早盘大幅上涨6.06%
Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.26%
市场透视 · 04-21
Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.26%
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.08%
市场透视 · 04-15
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.08%
Proqr Therapeutics N.V.盘中异动 下午盘股价大跌5.24%报1.81美元
市场透视 · 03-10
Proqr Therapeutics N.V.盘中异动 下午盘股价大跌5.24%报1.81美元
Proqr Therapeutics N.V.盘中异动 急速上涨5.69%报2.14美元
市场透视 · 03-05
Proqr Therapeutics N.V.盘中异动 急速上涨5.69%报2.14美元
Proqr Therapeutics N.V.盘中异动 临近收盘大幅下挫5.16%
市场透视 · 03-04
Proqr Therapeutics N.V.盘中异动 临近收盘大幅下挫5.16%
Proqr Therapeutics N.V.盘中异动 早盘急速上涨9.17%报2.55美元
市场透视 · 02-26
Proqr Therapeutics N.V.盘中异动 早盘急速上涨9.17%报2.55美元
Proqr Therapeutics N.V.盘中异动 股价大跌5.18%
市场透视 · 02-25
Proqr Therapeutics N.V.盘中异动 股价大跌5.18%
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.17%
市场透视 · 02-18
Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.17%
Proqr Therapeutics N.V.盘中异动 快速上涨5.29%
市场透视 · 02-14
Proqr Therapeutics N.V.盘中异动 快速上涨5.29%
Proqr Therapeutics N.V.盘中异动 早盘股价大跌5.19%报2.01美元
市场透视 · 02-11
Proqr Therapeutics N.V.盘中异动 早盘股价大跌5.19%报2.01美元
Proqr Therapeutics N.V.盘中异动 临近收盘股价大跌5.33%
市场透视 · 02-10
Proqr Therapeutics N.V.盘中异动 临近收盘股价大跌5.33%
加载更多
公司概况
公司名称:
ProQR Therapeutics N.V.
所属市场:
NASDAQ
上市日期:
--
主营业务:
ProQR Therapeutics N.V.是一家于2012年2月21日在荷兰成立的有限责任公司。该公司是一家生物技术公司,致力于创造变革性的RNA疗法,以改善受高度未满足医疗需求的疾病影响的患者和家庭的生活。为实现这一目标,该公司正在推进专有的Axiomer RNA编辑平台技术。公司候选产品旨在利用腺苷脱氨酶作用于RNA(“ADAR”)进行靶向RNA编辑,公司认为这有潜力成为一类新型创新药物,适用于广泛的治疗领域。
发行价格:
--
{"stockData":{"symbol":"PRQR","market":"US","secType":"STK","nameCN":"ProQR Therapeutics N.V.","latestPrice":2.36,"timestamp":1752177600000,"preClose":2.3,"halted":0,"volume":192258,"delay":0,"floatShares":66029401,"shares":105342963,"eps":-0.363555,"marketStatus":"盘前交易","change":0.06,"latestTime":"07-11 05:16:41 EDT","open":2.31,"high":2.3765,"low":2.22,"amount":440231.214852,"amplitude":0.068043,"askPrice":2.6,"askSize":100,"bidPrice":2.22,"bidSize":45,"shortable":3,"etf":0,"ttmEps":-0.363555,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1411012800000,"exchange":"NASDAQ","adjPreClose":2.36,"postHourTrading":{"tag":"盘后","latestPrice":2.38,"preClose":2.36,"latestTime":"19:44 EDT","volume":1779,"amount":4229.65,"timestamp":1752191058115},"volumeRatio":0.7773531332031672,"impliedVol":0.1323,"impliedVolPercentile":0.0763},"requestUrl":"/m/hq/s/PRQR","defaultTab":"news","newsList":[{"id":"2536753584","title":"Proqr Therapeutics N.V.2025财年第一财季实现净利润-10.61百万美元,同比减少27.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536753584","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536753584?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497625,"startTime":"0","endTime":"0","summary":"5月18日,Proqr Therapeutics N.V.公布财报,公告显示公司2025财年第一财季净利润为-10.61百万美元,同比减少27.68%;其中营业收入为4.76百万美元,同比减少1.45%,每股基本收益为-0.10美元。从资产负债表来看,Proqr Therapeutics N.V.总负债78.59百万美元,其中短期债务4.71百万美元,资产负债比为0.03,流动比率为0.05。机构评级:截至2025年5月18日,当前有9家机构对Proqr Therapeutics N.V.目标价做出预测,其中目标均价为8.95美元,其中最低目标价为3.97美元,最高目标价为13.91美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000129a6e2d7fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000129a6e2d7fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR"],"gpt_icon":0},{"id":"2535877398","title":"Proqr Therapeutics N.V.盘中异动 快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535877398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535877398?lang=zh_cn&edition=full","pubTime":"2025-05-16 03:36","pubTimestamp":1747337775,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日03时36分,Proqr Therapeutics N.V.股票出现波动,股价快速上涨5.16%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为2.10%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该信息摘要如下:奥本海默:维持ProQR Therapeutics评级,由优于大市调整至优于大市评级, 目标价由15.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516033615a6e0b6dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516033615a6e0b6dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","PRQR","BK4007"],"gpt_icon":0},{"id":"2535086679","title":"奥本海默:维持ProQR Therapeutics评级,由优于大市调整至优于大市评级, 目标价由15.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535086679","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535086679?lang=zh_cn&edition=full","pubTime":"2025-05-14 01:53","pubTimestamp":1747158832,"startTime":"0","endTime":"0","summary":"奥本海默:维持ProQR Therapeutics(PRQR.US)评级,由优于大市调整至优于大市评级, 目标价由15.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514015735975890f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514015735975890f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR"],"gpt_icon":0},{"id":"2533136183","title":"Proqr Therapeutics N.V.盘中异动 大幅下跌5.73%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533136183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533136183?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:48","pubTimestamp":1746712139,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时48分,Proqr Therapeutics N.V.股票出现波动,股价急速下跌5.73%。截至发稿,该股报1.48美元/股,成交量3.465万股,换手率0.03%,振幅6.69%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为3.01%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508214859aa2c8744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508214859aa2c8744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2533939053","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533939053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533939053?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:34","pubTimestamp":1746624873,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时34分,Proqr Therapeutics N.V.股票出现异动,股价快速拉升5.13%。截至发稿,该股报1.64美元/股,成交量1.8787万股,换手率0.02%,振幅2.56%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Rigel Pharmaceuticals, Inc.、Liminatus Pharma, Inc.涨幅较大,Theriva Biologics, Inc.、Zyversa Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为1302.17%、845.50%、158.46%,振幅较大的相关个股有Theriva Biologics, Inc.、Rigel Pharmaceuticals, Inc.、Polyrizon Ltd.,振幅分别为24.26%、15.72%、13.00%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213434975204dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213434975204dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","BK4007","LENZ"],"gpt_icon":0},{"id":"2532064828","title":"Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.19%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532064828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532064828?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:12","pubTimestamp":1746195141,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时12分,Proqr Therapeutics N.V.股票出现波动,股价急速上涨5.19%。截至发稿,该股报1.81美元/股,成交量12.8374万股,换手率0.12%,振幅4.36%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为1.01%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司唯一可报告的部门是发现和开发不同的基于 RNA 的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221221a4700b81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221221a4700b81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2531706753","title":"Proqr Therapeutics N.V.盘中异动 股价大涨5.16%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531706753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531706753?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:02","pubTimestamp":1745935356,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时02分,Proqr Therapeutics N.V.股票出现异动,股价大幅上涨5.16%。截至发稿,该股报1.62美元/股,成交量19.3685万股,换手率0.18%,振幅5.19%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为1.21%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃,换手率分别为141.32%、73.70%、23.95%,振幅较大的相关个股有Spruce Biosciences, Inc.、Ibio, Inc.、Cyclacel Pharmaceuticals, Inc.,振幅分别为41.73%、33.33%、26.68%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220237974a42ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220237974a42ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2530596911","title":"Proqr Therapeutics N.V.盘中异动 急速下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530596911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530596911?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:28","pubTimestamp":1745594926,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日23时28分,Proqr Therapeutics N.V.股票出现异动,股价快速跳水5.19%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Azitra Inc、Briacell Therapeutics Corp.、Pmgc Holdings Inc.较为活跃,换手率分别为259.70%、108.10%、72.12%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为90.48%、48.68%、33.35%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司唯一可报告的部门是发现和开发不同的基于 RNA 的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425232846aa2c7bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425232846aa2c7bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2529845095","title":"Proqr Therapeutics N.V.盘中异动 早盘大幅上涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529845095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529845095?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:44","pubTimestamp":1745329482,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时44分,Proqr Therapeutics N.V.股票出现异动,股价急速拉升6.06%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为1.36%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。它发现并开发 RNA 疗法,用于治疗患有严重遗传性罕见疾病的患者,例如囊性纤维化、Leber 先天性黑朦 10 型和营养不良性大疱性表皮松解症。该公司唯一可报告的部门是发现和开发不同的基于 RNA 的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214443a6c3ddbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214443a6c3ddbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","PRQR"],"gpt_icon":0},{"id":"2529802134","title":"Proqr Therapeutics N.V.盘中异动 早盘急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529802134?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:42","pubTimestamp":1745242936,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时42分,Proqr Therapeutics N.V.股票出现波动,股价大幅上涨5.26%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.54%。其相关个股中,Dogwood Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Evogene Ltd.较为活跃,换手率分别为707.66%、244.10%、194.22%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aptevo Therapeutics Inc.,振幅分别为37.03%、27.03%、23.20%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司唯一可报告的部门是发现和开发不同的基于 RNA 的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214216973f74ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214216973f74ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2527844119","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527844119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527844119?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:00","pubTimestamp":1744729228,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时00分,Proqr Therapeutics N.V.股票出现波动,股价大幅上涨5.08%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.09%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230029a6bb6118&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230029a6bb6118&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ","BK4007"],"gpt_icon":0},{"id":"2518209244","title":"Proqr Therapeutics N.V.盘中异动 下午盘股价大跌5.24%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209244?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631830,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分,Proqr Therapeutics N.V.股票出现波动,股价急速下跌5.24%。截至发稿,该股报1.81美元/股,成交量51.4288万股,换手率0.49%,振幅8.30%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为0.55%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023710abf36c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023710abf36c6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2517607943","title":"Proqr Therapeutics N.V.盘中异动 急速上涨5.69%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517607943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:41","pubTimestamp":1741185695,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时41分,Proqr Therapeutics N.V.股票出现异动,股价急速上涨5.69%。截至发稿,该股报2.14美元/股,成交量1.2014万股,换手率0.01%,振幅5.94%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为0.69%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224135989d4830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224135989d4830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4139","LENZ"],"gpt_icon":0},{"id":"2517986724","title":"Proqr Therapeutics N.V.盘中异动 临近收盘大幅下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517986724?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:00","pubTimestamp":1741122024,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日05时00分,Proqr Therapeutics N.V.股票出现异动,股价快速跳水5.16%。截至发稿,该股报2.02美元/股,成交量48.0434万股,换手率0.45%,振幅5.16%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.31%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050024989c05b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050024989c05b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","LENZ","BK4139"],"gpt_icon":0},{"id":"2514856100","title":"Proqr Therapeutics N.V.盘中异动 早盘急速上涨9.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856100?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:43","pubTimestamp":1740580999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时43分,Proqr Therapeutics N.V.股票出现波动,股价快速拉升9.17%。截至发稿,该股报2.55美元/股,成交量466股,换手率0.00%,振幅0.85%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.48%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224319abddf00c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224319abddf00c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2514129360","title":"Proqr Therapeutics N.V.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514129360?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:21","pubTimestamp":1740504081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时21分,Proqr Therapeutics N.V.股票出现异动,股价快速跳水5.18%。截至发稿,该股报2.38美元/股,成交量11.2507万股,换手率0.11%,振幅4.78%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为0.27%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601212298926f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601212298926f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2512216546","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512216546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512216546?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889738,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分,Proqr Therapeutics N.V.股票出现波动,股价急速上涨5.17%。截至发稿,该股报2.55美元/股,成交量1.5655万股,换手率0.01%,振幅4.96%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体涨幅为0.55%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224219962799bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224219962799bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2511861594","title":"Proqr Therapeutics N.V.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511861594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511861594?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:10","pubTimestamp":1739556617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时10分,Proqr Therapeutics N.V.股票出现异动,股价快速上涨5.29%。截至发稿,该股报2.39美元/股,成交量5.2392万股,换手率0.05%,振幅5.73%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.54%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215021017abcf34de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215021017abcf34de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2510380549","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大跌5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380549?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284623,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分,Proqr Therapeutics N.V.股票出现异动,股价急速下跌5.19%。截至发稿,该股报2.01美元/股,成交量3.8138万股,换手率0.04%,振幅4.75%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.91%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223703961f48b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223703961f48b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2510281861","title":"Proqr Therapeutics N.V.盘中异动 临近收盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510281861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510281861?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:49","pubTimestamp":1739220583,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时49分,Proqr Therapeutics N.V.股票出现异动,股价快速下挫5.33%。截至发稿,该股报2.13美元/股,成交量22.8712万股,换手率0.22%,振幅4.00%。Proqr Therapeutics N.V.股票所在的生物技术行业中,整体跌幅为0.94%。Proqr Therapeutics N.V.公司简介:ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化,Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211044943a240ef11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211044943a240ef11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.proqr.com","stockEarnings":[{"period":"1week","weight":0.0826},{"period":"1month","weight":0.3333},{"period":"3month","weight":1.1071},{"period":"6month","weight":-0.0248},{"period":"1year","weight":0.3801},{"period":"ytd","weight":-0.1094}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProQR Therapeutics N.V.是一家于2012年2月21日在荷兰成立的有限责任公司。该公司是一家生物技术公司,致力于创造变革性的RNA疗法,以改善受高度未满足医疗需求的疾病影响的患者和家庭的生活。为实现这一目标,该公司正在推进专有的Axiomer RNA编辑平台技术。公司候选产品旨在利用腺苷脱氨酶作用于RNA(“ADAR”)进行靶向RNA编辑,公司认为这有潜力成为一类新型创新药物,适用于广泛的治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.140897},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.09206},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.002169},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.01976},{"month":5,"riseRate":0.454545,"avgChangeRate":0.024621},{"month":6,"riseRate":0.545455,"avgChangeRate":0.033196},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.01695},{"month":8,"riseRate":0.8,"avgChangeRate":0.085978},{"month":9,"riseRate":0.3,"avgChangeRate":0.084324},{"month":10,"riseRate":0.272727,"avgChangeRate":0.015855},{"month":11,"riseRate":0.636364,"avgChangeRate":0.058476},{"month":12,"riseRate":0.636364,"avgChangeRate":0.232386}],"exchange":"NASDAQ","name":"ProQR Therapeutics N.V.","nameEN":"ProQR Therapeutics NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProQR Therapeutics N.V.,PRQR,ProQR Therapeutics N.V.股票,ProQR Therapeutics N.V.股票老虎,ProQR Therapeutics N.V.股票老虎国际,ProQR Therapeutics N.V.行情,ProQR Therapeutics N.V.股票行情,ProQR Therapeutics N.V.股价,ProQR Therapeutics N.V.股市,ProQR Therapeutics N.V.股票价格,ProQR Therapeutics N.V.股票交易,ProQR Therapeutics N.V.股票购买,ProQR Therapeutics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}